x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Long-Term, Open Label Study to Evaluate the Safety of M207 (Zolmitriptan Intracutaneous Microneedle System) in the Acute Treatment of Migraine
Principal Investigator (?)
Study Number
F18016
Summary
This is an open-label, twelve-month safety study. There is a screening period followed by a run-in period to record migraine activity. Qualified subjects will receive study medication for up to twelve months for the treatment of multiple migraine attacks. Using the eDiary to confirm they are experiencing a qualified migraine, subjects will self-administer the patches and respond to questions in the eDiary post treatment administration. 
Phase (?)
Phase III
Sponsor (?)
Contact

Tara Ellis

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0